Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trialMeinolf Karthaus, Peter Reichardt, David Irwin et al.|Annals of Oncology|2005Cited by 223
Oxaliplatin (OX) after irinotecan (IRI): antitumour activity and clinical benefit of 3rd and higher line chemotherapy with ox for patients (pts) with metastatic colorectal cancer (MCC) after failure of IRIAlbrecht Kretzschmar, Peter Reichardt, Jochen Metzger et al.|European Journal of Cancer|1999Cited by 4